Compare WVE & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | TSAT |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 744.8M | 697.5M |
| IPO Year | 2015 | 2021 |
| Metric | WVE | TSAT |
|---|---|---|
| Price | $3.45 | $44.35 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 19 | 5 |
| Target Price | $18.06 | ★ $65.59 |
| AVG Volume (30 Days) | ★ 2.9M | 96.3K |
| Earning Date | 11-09-2026 | 11-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $3,704,000.00 | N/A |
| Revenue This Year | $19.21 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 149.43 | N/A |
| 52 Week Low | $3.43 | $23.01 |
| 52 Week High | $21.73 | $61.54 |
| Indicator | WVE | TSAT |
|---|---|---|
| Relative Strength Index (RSI) | 25.92 | 42.53 |
| Support Level | N/A | $41.65 |
| Resistance Level | $6.33 | $45.19 |
| Average True Range (ATR) | 0.23 | 2.61 |
| MACD | -0.02 | -0.39 |
| Stochastic Oscillator | 8.56 | 14.14 |
WAVE Life Sciences Inc is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. The company has two operating segments: GEO services (GEO) segment that refers to the operation of the fleet of GEO satellite and LEO services (LEO) segment that refers to the deployment and operation of the Telesat Lightspeed constellation Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.